Microbial Profiles and Antibiotic Resistance Patterns in Neonatal Sepsis: A Frequency Analysis
Microbial Profiles and Antibiotic Resistance Patterns in Neonatal Sepsis
DOI:
https://doi.org/10.54393/pjhs.v7i7.2663Keywords:
Neonatal Sepsis, Escherichia Coli, Antibiotic Susceptibility, Antimicrobial Resistance, NeonatesAbstract
Neonatal sepsis remains an important cause of neonatal morbidity, mortality, and prolonged hospitalization, and the spectrum of causative organisms and their antibiotic susceptibility varies across settings. Updated local microbiological data are therefore essential for appropriate empirical therapy and antimicrobial stewardship. Objective: To determine the frequency of different microorganisms and their antibiotic susceptibility pattern in neonatal sepsis. Methods: This descriptive cross-sectional study was conducted in the Pediatric Ward of Bahawal Victoria Hospital, Bahawalpur, from 09-02-2024 to 08-08-2024. A total of 119 term neonates with clinical features of sepsis were included. Blood cultures were processed by standard microbiological methods, and antibiotic susceptibility was assessed against commonly used antibiotics. Data were analyzed using SPSS version 25.0. Post-stratification Chi-square test was applied, and p≤0.05 was considered statistically significant. Results: Escherichia coli was the most frequent isolate, identified in 41 (34.45%) cases, followed by Staphylococcus aureus in 24 (20.17%) and Klebsiella species in 19 (15.97%). Overall, gram-negative organisms predominated. Amikacin showed the highest sensitivity, 111 (93.28%), followed by gentamicin, 107 (89.92%), whereas relatively lower sensitivity was observed for ceftazidime, 85 (71.43%), cefotaxime, 86 (72.27%), and tobramycin, 91 (76.47%). Stratification by age and gender showed no statistically significant differences in microorganism distribution or antibiotic susceptibility (all p>0.05). Conclusions: Escherichia coli was the leading pathogen in neonatal sepsis in this cohort. The comparatively higher sensitivity to amikacin and gentamicin, together with lower sensitivity to some cephalosporins and tobramycin, supports the need for hospital-specific empirical antibiotic policies, regular antibiogram updates, and antimicrobial stewardship.
References
Fleischmann C, Reichert F, Cassini A, Horner R, Harder T, Markwart R et al. Global Incidence and Mortality of Neonatal Sepsis: A Systematic Review and Meta-Analysis. Archives of Disease in Childhood. 2021 Aug; 106(8): 745-752. doi: 10.1136/archdischild-2020-320217. DOI: https://doi.org/10.1136/archdischild-2020-320217
Milton R, Gillespie D, Dyer C, Taiyari K, Carvalho MJ, Thomson K et al. Neonatal Sepsis and Mortality in Low-Income and Middle-Income Countries from a Facility-Based Birth Cohort: An International Multisite Prospective Observational Study. The Lancet Global Health. 2022 May; 10(5): 661-672.
Miselli F, Cuoghi Costantini R, Creti R, Sforza F, Fanaro S et al. Escherichia coli is Overtaking Group B Streptococcus in Early-Onset Neonatal Sepsis. Microorganisms. 2022 Sep; 10(10): 1878. doi: 10.3390/microorganisms10101878. DOI: https://doi.org/10.3390/microorganisms10101878
Mariani M, Parodi A, Minghetti D, Ramenghi LA, Palmero C, Ugolotti E et al. Early and Late Onset Neonatal Sepsis: Epidemiology and Effectiveness of Empirical Antibacterial Therapy in a III-level Neonatal Intensive Care Unit. Antibiotics. 2022 Feb; 11(2): 284. doi: 10.3390/antibiotics11020284. DOI: https://doi.org/10.3390/antibiotics11020284
Minotti C, Di Caprio A, Facchini L, Bedetti L, Miselli F, Rossi C et al. Antimicrobial Resistance Pattern and Empirical Antibiotic Treatments in Neonatal Sepsis: A Retrospective, Single-Center, 12-Year Study. Antibiotics. 2023 Sep; 12(10): 1488. doi: 10.3390/antibiotics12101488. DOI: https://doi.org/10.3390/antibiotics12101488
Poggi C and Dani C. New Antimicrobials for the Treatment of Neonatal Sepsis Caused by Multi-Drug-Resistant Bacteria: A Systematic Review. Antibiotics. 2023 May; 12(6): 956. doi: 10.3390/antibiotics12060956. DOI: https://doi.org/10.3390/antibiotics12060956
Mascarenhas D, Ho MS, Ting J, Shah PS. Antimicrobial Stewardship Programs in Neonates: A Meta-Analysis. Pediatrics. 2024 Jun; 153(6): 2023065091. doi: 10.1542/peds.2023-065091. DOI: https://doi.org/10.1542/peds.2023-065091
Vogiantzi G, Metallinou D, Tigka M, Deltsidou A, Nanou CI. Bloodstream Infections in the Neonatal Intensive Care Unit: A Systematic Review of The Literature. Cureus. 2024 Aug; 16(8): 1-15. doi: 10.7759/cureus.68057. DOI: https://doi.org/10.7759/cureus.68057
Kasem S, Elhadidi A, Omar N, Dawoud T, Sa'da OA, Rahmani A et al. Microbiological Characteristics and Resistance Patterns in a Neonatal Intensive Care Unit: A Retrospective Surveillance Study. Cureus. 2024 Mar 12;16(3): 1-15. doi: 10.7759/cureus.56027. DOI: https://doi.org/10.7759/cureus.56027
Jihwaprani MC, Sula I, Coha D, Alhebshi A, Alsamal M, Hassaneen AM et al. Bacterial Profile and Antimicrobial Susceptibility Patterns of Common Neonatal Sepsis Pathogens in Gulf Cooperation Council countries: A systematic review and meta-analysis. Qatar Medical Journal. 2024; 4: 62. doi: 10.5339/qmj.2024.62. DOI: https://doi.org/10.5339/qmj.2024.62
Majigo M, Makupa J, Mwazyunga Z, Luoga A, Kisinga J, Mwamkoa B et al. Bacterial Aetiology of Neonatal Sepsis and Antimicrobial Resistance Pattern at the Regional Referral Hospital, Dar es Salaam, Tanzania; A Call to Strengthen Antibiotic Stewardship Program. Antibiotics. 2023 Apr; 12(4): 767. doi: 10.3390/antibiotics12040767. DOI: https://doi.org/10.3390/antibiotics12040767
Karimi F, Lewis LE, Thunga G, Najmi A, Sahu P, Kunhikatta V. Relationship Between Antibiotic Consumption Pattern and Antibiotic Resistance in Neonatal Sepsis. Medicine and Pharmacy Reports. 2023 Jan; 96(1): 35. doi:
Siwakoti S, Sah R, Singh RR, Khanal B. Clinical, Bacteriological Profile and Outcome of Neonatal Sepsis. Journal of Nepal Health Research Council. 2022; 20(4): 967-972. doi: 10.15386/mpr-2409. DOI: https://doi.org/10.15386/mpr-2409
Özkavaklı A, İmamoğlu EY, Önder N, İmamoğlu S, Ovalı HF. Trends in Causative Organisms and Antimicrobial Resistance in Late-Onset Neonatal Sepsis. Turkish Archives of Pediatrics. 2024 Jul; 59(4): 375. doi: 10.5152/TurkArchPediatr.2024.24006. DOI: https://doi.org/10.5152/TurkArchPediatr.2024.24006
Almohammady MN, Eltahlawy EM, Reda NM. Pattern of Bacterial Profile and Antibiotic Susceptibility Among Neonatal Sepsis Cases at Cairo University Children's Hospital. Journal of Taibah University Medical Sciences. 2020 Feb; 15(1): 39-47. doi: 10.1016/j.jtumed.2019.12.005. DOI: https://doi.org/10.1016/j.jtumed.2019.12.005
Nguyen TQ, Do TH, Van Nguyen T, Pham TN, Hoang TB. Neonatal Sepsis in Vietnam: Bacterial Profiles and Antibiotic Susceptibility in a Tertiary Care Setting. American Journal of Infection Control. 2025 Apr; 53(4): 453-457. doi: 10.1016/j.ajic.2024.12.016. DOI: https://doi.org/10.1016/j.ajic.2024.12.016
Yang X, Ren L, Gong M, Lu Y, Ding X. Impacts of the COVID-19 Pandemic on Culture-Proven Sepsis in Neonates. Frontiers in Cellular and Infection Microbiology. 2024 Jun; 14: 1-10. doi: 10.3389/fcimb.2024.1391929. DOI: https://doi.org/10.3389/fcimb.2024.1391929
Utomo MT, Sumitro KR, Etika R, Widodo AD. Current-Proven Neonatal Sepsis in Indonesian Tertiary Neonatal Intensive Care Unit: A Hematological and Microbiological Profile. Iranian Journal of Microbiology. 2021 Jun; 13(3): 266. doi: 10.18502/ijm.v13i3.6386. DOI: https://doi.org/10.18502/ijm.v13i3.6386
Solomon S, Akeju O, Odumade OA, Ambachew R, Gebreyohannes Z, Van Wickle K et al. Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. PloS one. 2021 Aug; 16(8): 255410. doi: 10.1371/journal.pone.0255410. DOI: https://doi.org/10.1371/journal.pone.0255410
Lee P, Sin E, Yip KT, Ng K. A 10-Year Study of Neonatal Sepsis from Tuen Mun Hospital, Hong Kong. Pathogens. 2025 Mar; 14(3): 276. doi: 10.3390/pathogens14030276. DOI: https://doi.org/10.3390/pathogens14030276
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
